WG
SILK

Winton Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Winton Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,704
Closed -$693K – 1173
2023
Q1 		$693K Buy
17,704
+739
+4% +$36.1K 0.04% 570
2022
Q4 		$897K Sell
16,965
-358
-2% -$17.4K 0.06% 444
2022
Q3 		$780K Sell
17,323
-3,539
-17% -$152K 0.05% 492
2022
Q2 		$759K Buy
20,862
+2,328
+13% +$84.6K 0.04% 575
2022
Q1 		$765K Buy
18,534
+2,984
+19% +$105K 0.04% 556
2021
Q4 		$663K Buy
15,550
+1,833
+13% +$91.7K 0.04% 593
2021
Q3 		$755K Sell
13,717
-3,380
-20% -$177K 0.04% 651
2021
Q2 		$818K Buy
17,097
+1,064
+7% +$54.2K 0.04% 642
2021
Q1 		$812K Buy
16,033
+1,089
+7% +$60.5K 0.05% 590
2020
Q4 		$941K Sell
14,944
-25,150
-63% -$1.56M 0.07% 436
2020
Q3 		$2.69M Buy
+40,094
New +$2.19M 0.09% 387

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Winton Group's SILK Position: Q2 2023 in Review

Winton Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 17,704 shares — an estimated $693K sold.

Winton Group first reported a position in SILK in Q3 2020 and held it in 11 quarters. The position peaked at $2.69M in Q3 2020. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

  • Winton Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Winton Group sold 17,704 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $693K.
  • Winton Group first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Winton Group's Silk Road Medical, Inc. Common Stock position peaked at $2.69M in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Winton Group's 13F filing for Q2 2023, filed 14 Aug 2023.